Search results
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 7 days agoAfter a median follow-up time of 112 days — roughly three to four months — the shot proved 83.7% ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 4 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 7 days agoThe FDA has approved Moderna's RSV vaccine for older adults. The Food and Drug Administration on...
FDA approves Moderna’s mRNA RSV vaccine
The Hill· 7 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 24 hours agoModerna expects to have mRESVIA available for eligible populations in the US by the 2024/2025 RSV...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoTwo other RSV vaccines, Arexvy from GlaxoSmithKline (GSK...vaccine technology used in COVID vaccines...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 7 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 2 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
Analysis | Four questions for today’s Fauci hearing
Washington Post· 4 days agoThe Texas Supreme Court rejected a lawsuit that sought to clarify exceptions to the state’s abortion laws. The longtime infectious-disease expert is back...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 7 days agoToday, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV ...